Lista de obras - Jeffrey J Tosoian - Dominio Público Uruguay

A Novel Approach for Performing Bone Marrow Aspiration at the Time of Radical Prostatectomy

artículo científico publicado en 2016

A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer

scientific article published on 05 December 2020

A novel risk scoring system reliably predicts readmission after pancreatectomy

artículo científico publicado en 2015

Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens

artículo científico publicado en 2017

Accuracy of PCA3 measurement in predicting short-term biopsy progression in an active surveillance program

artículo científico publicado en 2009

Active Surveillance Program for Prostate Cancer: An Update of the Johns Hopkins Experience ⬇️

artículo científico publicado el 4 de abril de 2011

Active Surveillance of Grade Group 1 Prostate Cancer: Long-term Outcomes from a Large Prospective Cohort

artículo científico publicado en 2020

Active Surveillance of Localized Prostate Cancer: Acknowledging Uncertainty

artículo científico publicado en 2016

Active Surveillance of Prostate Cancer: Use, Outcomes, Imaging, and Diagnostic Tools

artículo científico publicado en 2016

Active surveillance for prostate cancer: current evidence and contemporary state of practice

artículo científico publicado en 2016

Active surveillance of prostate cancer: Current state of practice and utility of multiparametric magnetic resonance imaging.

artículo científico publicado en 2017

Adverse Pathologic Findings for Men Electing Immediate Radical Prostatectomy: Defining a Favorable Intermediate-Risk Group

artículo científico

Association of [-2]proPSA with biopsy reclassification during active surveillance for prostate cancer

artículo científico publicado en 2012

Association of tumor-infiltrating T-cell density with molecular subtype, racial ancestry and clinical outcomes in prostate cancer.

artículo científico publicado en 2018

Biologic Significance of Magnetic Resonance Imaging Invisibility in Localized Prostate Cancer

scientific article published on 12 June 2019

Biomarkers in active surveillance.

artículo científico publicado en 2018

Biopsy Cell Cycle Proliferation Score Predicts Adverse Surgical Pathology in Localized Renal Cell Carcinoma

scientific article published on 14 September 2020

CDKN1B Deletions are Associated with Metastasis in African American Men with Clinically Localized, Surgically Treated Prostate Cancer

artículo científico publicado en 2020

Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study

artículo científico publicado en 2018

Clinical Utility of Gene Expression Classifiers in Men With Newly Diagnosed Prostate Cancer

artículo científico publicado en 2018

Clinical Validation of the 2005 ISUP Gleason Grading System in a Cohort of Intermediate and High Risk Men Undergoing Radical Prostatectomy

artículo científico publicado en 2016

Clinical, pathologic, and oncologic findings of radical prostatectomy patients with extraprostatic extension diagnosed on pre-operative prostate biopsy

scientific article published on 01 May 2019

Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer

artículo científico publicado en 2017

Combining immune check-point blockade and cryoablation in an immunocompetent hormone sensitive murine model of prostate cancer

artículo científico publicado en 2018

Concurrent Androgen Deprivation with Radiotherapy: A Cautionary Tale of "Do As I Say, Not As I Do"?

artículo científico publicado en 2016

Correlation of PSMA-Targeted 18F-DCFPyL PET/CT Findings With Immunohistochemical and Genomic Data in a Patient With Metastatic Neuroendocrine Prostate Cancer

artículo científico publicado en 2016

Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical Prostatectomy

scientific article published on 14 May 2018

Diagnosing and Treating Inflammatory Myofibroblastic Tumor of the Bladder.

artículo científico publicado en 2016

Distant Metastases From a Small Renal Cell Carcinoma: A Case Report

artículo científico publicado en 2015

Do patients who undergo multiparametric MRI for prostate cancer benefit from additional staging imaging? Results from a statewide collaborative

artículo científico publicado en 2020

Does benign prostatic hyperplasia treatment with alpha-blockers affect prostate cancer risk?

artículo científico publicado en 2013

Does time from diagnosis to treatment of high- or very-high-risk prostate cancer affect outcome?

artículo científico publicado en 2019

Downgrading from Biopsy Grade Group 4 Prostate Cancer in Patients Undergoing Radical Prostatectomy for High or Very High Risk Prostate Cancer

scientific article published on 07 April 2020

Dynamic Contrast Enhanced Magnetic Resonance Imaging Improves Classification of Prostate Lesions: A Study of Pathological Outcomes on Targeted Prostate Biopsy

artículo científico publicado en 2017

EDITORIAL COMMENT

scientific article published on 01 August 2019

EDITORIAL COMMENT

Early hospital readmission for gastrointestinal-related complications predicts long-term mortality after pancreatectomy

artículo científico publicado en 2015

Editorial Comment

artículo científico publicado en 2016

Editorial Comment

artículo científico publicado en 2019

Elevated Prostate Health Index (phi) and Biopsy Reclassification During Active Surveillance of Prostate Cancer

artículo científico publicado en 2016

Erectile Dysfunction Treatment Following Radical Cystoprostatectomy: Analysis of a Nationwide Insurance Claims Database

artículo científico publicado en 2017

Evaluation of gender-based disparities in time from initial haematuria presentation to upper tract urothelial carcinoma diagnosis: analysis of a nationwide insurance claims database

artículo científico publicado en 2017

Frailty as a marker of adverse outcomes in patients with bladder cancer undergoing radical cystectomy

artículo científico publicado en 2016

Glutamine tract length of human androgen receptors affects hormone-dependent and -independent prostate cancer in mice

artículo científico publicado en 2007

Impact of the MyProstateScore (MPS) test on the clinical decision to undergo prostate biopsy: results from a contemporary academic practice

artículo científico publicado en 2020

Implementation of a Surgeon-Level Comparative Quality Performance Review to Improve Positive Surgical Margin Rates during Radical Prostatectomy

artículo científico publicado en 2016

Indications for intervention during active surveillance of prostate cancer: a comparison of the Johns Hopkins and Prostate Cancer Research International Active Surveillance (PRIAS) protocols

artículo científico publicado en 2014

Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer

artículo científico publicado en 2015

Longitudinal assessment of urinary PCA3 for predicting prostate cancer grade reclassification in favorable-risk men during active surveillance.

artículo científico publicado en 2017

Managing high-grade prostatic intraepithelial neoplasia (HGPIN) and atypical glands on prostate biopsy

artículo científico

Metastatic Prostate Cancer Diagnosed by Bone Marrow Aspiration in an Elderly Man Not Undergoing PSA Screening

artículo científico publicado en 2017

Molecular Analysis of Low Grade Prostate Cancer Using a Genomic Classifier of Metastatic Potential

artículo científico publicado en 2016

Molecular heterogeneity of localized prostate cancer: more different than alike

artículo científico publicado en 2017

Older Age Predicts Biopsy and Radical Prostatectomy Grade Reclassification to Aggressive Prostate Cancer in Men on Active Surveillance

scientific article published on 01 January 2019

Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations

artículo científico publicado en 2016

Outcomes of arterial resection during pancreatectomy for tumor

artículo científico publicado en 2015

Outcomes of very high-risk prostate cancer after radical prostatectomy: Validation study from 3 centers

artículo científico publicado en 2018

Overtreatment and underutilization of watchful waiting in men with limited life expectancy: an analysis of the Michigan Urological Surgery Improvement Collaborative Registry

artículo científico publicado en 2020

PSA and beyond: the past, present, and future of investigative biomarkers for prostate cancer

artículo científico publicado en 2010

PTEN Loss in Gleason Score 3 + 4 = 7 Prostate Biopsies is Associated with Nonorgan Confined Disease at Radical Prostatectomy

artículo científico publicado en 2016

PTEN status assessment in the Johns Hopkins active surveillance cohort

artículo científico publicado en 2018

Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery

artículo científico publicado en 2015

Pathological Outcomes in Men with Low Risk and Very Low Risk Prostate Cancer: Implications on the Practice of Active Surveillance ⬇️

artículo científico publicado el 30 de abril de 2013

Patients with Intermediate Risk Prostate Cancer May be Good Candidates for Active Surveillance: Con

artículo científico publicado en 2017

Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier

scientific article published on 30 March 2020

Pharmacodynamic and pharmacokinetic neoadjuvant study of hedgehog pathway inhibitor Sonidegib (LDE-225) in men with high-risk localized prostate cancer undergoing prostatectomy

artículo científico publicado en 2017

Prediction of pathological stage based on clinical stage, serum prostate-specific antigen, and biopsy Gleason score: Partin Tables in the contemporary era.

artículo científico publicado en 2016

Prevalence and Prognostic Significance of PTEN Loss in African-American and European-American Men Undergoing Radical Prostatectomy

artículo científico publicado en 2016

Prognostic utility of biopsy-derived cell cycle progression score in patients with National Comprehensive Cancer Network low-risk prostate cancer undergoing radical prostatectomy: implications for treatment guidance

artículo científico publicado en 2017

Prognostic value of prostate biopsy grade: forever a product of sampling

artículo científico publicado en 2017

Prospective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsy

artículo científico publicado en 2022

Prostate Health Index (PHI) Predicts High-stage Pathology in African American Men.

artículo científico publicado en 2015

Prostate Health Index and Multiparametric MRI to Predict Prostate Cancer Grade Reclassification in Active Surveillance

scientific article published on 04 May 2020

Prostate Health Index density improves detection of clinically significant prostate cancer

artículo científico publicado en 2017

Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis

scientific article published on 13 April 2019

Racial Variations in Prostate Cancer Molecular Subtypes and Androgen Receptor Signaling Reflect Anatomic Tumor Location

artículo científico publicado en 2015

Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer

artículo científico publicado en 2018

Radical retropubic prostatectomy: comparison of the open and robotic approaches for treatment of prostate cancer.

artículo científico publicado en 2012

Readmissions after complex aneurysm repair are frequent, costly, and primarily at nonindex hospitals

scientific article published on 12 October 2014

Risk Stratification in Active Surveillance: A Dynamic, Ever-Evolving Practice

artículo científico publicado en 2018

Risk prediction tool for grade re-classification in men with favourable-risk prostate cancer on active surveillance

artículo científico publicado en 2016

SPINK1 expression is enriched in African American prostate cancer but is not associated with altered immune infiltration or oncologic outcomes post-prostatectomy

artículo científico publicado en 2019

Serial Molecular Profiling of Low-grade Prostate Cancer to Assess Tumor Upgrading: A Longitudinal Cohort Study

artículo científico publicado en 2020

Somatic molecular subtyping of prostate tumors from HOXB13 G84E carriers

artículo científico publicado en 2017

Stratifying Risk for Men With Low-Volume Intermediate-Risk Prostate Cancer-Reply

artículo científico publicado en 2018

Subtyping the Risk of Intermediate Risk Prostate Cancer for Active Surveillance Based on Adverse Pathology at Radical Prostatectomy

artículo científico publicado en 2018

Surgical management of high-risk, localized prostate cancer

scientific article published on 10 November 2020

The Androgen Signaling Axis and Risk Stratification for High-grade Prostate Cancer

artículo científico publicado en 2018

The History of Prostate Cancer From Antiquity: Review of Paleopathological Studies

artículo científico publicado en 2016

The Role of Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Biopsy in Active Surveillance

artículo científico publicado en 2016

The effect of repair costs on the profitability of a ureteroscopy program

artículo científico publicado en 2014

The effect of socioeconomic status, race, and insurance type on newly diagnosed metastatic prostate cancer in the United States (2004-2013).

artículo científico publicado en 2017

Tissue-based genomics: which test and when

artículo científico publicado en 2019

Tracking early readmission after pancreatectomy to index and nonindex institutions: a more accurate assessment of readmission

artículo científico publicado en 2015

Translating Science to Medicine: When Will the Rubber Meet the Road?

artículo científico publicado en 2019

Tumor Volume on Biopsy in Low Risk Prostate Cancer Managed with Active Surveillance

artículo científico publicado en 2017

Unraveling Prostate Cancer Genomics, Pathology, and Magnetic Resonance Imaging Visibility

artículo científico publicado en 2019

Unscreened older men diagnosed with prostate cancer are at increased risk of aggressive disease.

artículo científico publicado en 2017

Urinary Biomarkers for Prostate Cancer

artículo científico publicado en 2016

Use of the MyProstateScore (MPS) Test to Rule Out Clinically-Significant Cancer: Validation of a Straightforward Clinical Testing Approach

artículo científico publicado en 2020

Use of the Prostate Health Index for detection of prostate cancer: results from a large academic practice

artículo científico publicado en 2017

Validation of the Decipher Test for predicting adverse pathology in candidates for prostate cancer active surveillance

scientific article published on 12 December 2018

Lista de obras de Jeffrey J Tosoian

A Novel Approach for Performing Bone Marrow Aspiration at the Time of Radical Prostatectomy

A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer

A novel risk scoring system reliably predicts readmission after pancreatectomy

Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens

Accuracy of PCA3 measurement in predicting short-term biopsy progression in an active surveillance program

Active Surveillance Program for Prostate Cancer: An Update of the Johns Hopkins Experience ⬇️

Active Surveillance of Grade Group 1 Prostate Cancer: Long-term Outcomes from a Large Prospective Cohort

Active Surveillance of Localized Prostate Cancer: Acknowledging Uncertainty

Active Surveillance of Prostate Cancer: Use, Outcomes, Imaging, and Diagnostic Tools

Active surveillance for prostate cancer: current evidence and contemporary state of practice

Active surveillance of prostate cancer: Current state of practice and utility of multiparametric magnetic resonance imaging.

Adverse Pathologic Findings for Men Electing Immediate Radical Prostatectomy: Defining a Favorable Intermediate-Risk Group

Association of [-2]proPSA with biopsy reclassification during active surveillance for prostate cancer

Association of tumor-infiltrating T-cell density with molecular subtype, racial ancestry and clinical outcomes in prostate cancer.

Biologic Significance of Magnetic Resonance Imaging Invisibility in Localized Prostate Cancer

Biomarkers in active surveillance.

Biopsy Cell Cycle Proliferation Score Predicts Adverse Surgical Pathology in Localized Renal Cell Carcinoma

CDKN1B Deletions are Associated with Metastasis in African American Men with Clinically Localized, Surgically Treated Prostate Cancer

Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study

Clinical Utility of Gene Expression Classifiers in Men With Newly Diagnosed Prostate Cancer

Clinical Validation of the 2005 ISUP Gleason Grading System in a Cohort of Intermediate and High Risk Men Undergoing Radical Prostatectomy

Clinical, pathologic, and oncologic findings of radical prostatectomy patients with extraprostatic extension diagnosed on pre-operative prostate biopsy

Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer

Combining immune check-point blockade and cryoablation in an immunocompetent hormone sensitive murine model of prostate cancer

Concurrent Androgen Deprivation with Radiotherapy: A Cautionary Tale of "Do As I Say, Not As I Do"?

Correlation of PSMA-Targeted 18F-DCFPyL PET/CT Findings With Immunohistochemical and Genomic Data in a Patient With Metastatic Neuroendocrine Prostate Cancer

Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical Prostatectomy

Diagnosing and Treating Inflammatory Myofibroblastic Tumor of the Bladder.

Distant Metastases From a Small Renal Cell Carcinoma: A Case Report

Do patients who undergo multiparametric MRI for prostate cancer benefit from additional staging imaging? Results from a statewide collaborative

Does benign prostatic hyperplasia treatment with alpha-blockers affect prostate cancer risk?

Does time from diagnosis to treatment of high- or very-high-risk prostate cancer affect outcome?

Downgrading from Biopsy Grade Group 4 Prostate Cancer in Patients Undergoing Radical Prostatectomy for High or Very High Risk Prostate Cancer

Dynamic Contrast Enhanced Magnetic Resonance Imaging Improves Classification of Prostate Lesions: A Study of Pathological Outcomes on Targeted Prostate Biopsy

EDITORIAL COMMENT

EDITORIAL COMMENT

Early hospital readmission for gastrointestinal-related complications predicts long-term mortality after pancreatectomy

Editorial Comment

Editorial Comment

Elevated Prostate Health Index (phi) and Biopsy Reclassification During Active Surveillance of Prostate Cancer

Erectile Dysfunction Treatment Following Radical Cystoprostatectomy: Analysis of a Nationwide Insurance Claims Database

Evaluation of gender-based disparities in time from initial haematuria presentation to upper tract urothelial carcinoma diagnosis: analysis of a nationwide insurance claims database

Frailty as a marker of adverse outcomes in patients with bladder cancer undergoing radical cystectomy

Glutamine tract length of human androgen receptors affects hormone-dependent and -independent prostate cancer in mice

Impact of the MyProstateScore (MPS) test on the clinical decision to undergo prostate biopsy: results from a contemporary academic practice

Implementation of a Surgeon-Level Comparative Quality Performance Review to Improve Positive Surgical Margin Rates during Radical Prostatectomy

Indications for intervention during active surveillance of prostate cancer: a comparison of the Johns Hopkins and Prostate Cancer Research International Active Surveillance (PRIAS) protocols

Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer

Longitudinal assessment of urinary PCA3 for predicting prostate cancer grade reclassification in favorable-risk men during active surveillance.

Managing high-grade prostatic intraepithelial neoplasia (HGPIN) and atypical glands on prostate biopsy

Metastatic Prostate Cancer Diagnosed by Bone Marrow Aspiration in an Elderly Man Not Undergoing PSA Screening

Molecular Analysis of Low Grade Prostate Cancer Using a Genomic Classifier of Metastatic Potential

Molecular heterogeneity of localized prostate cancer: more different than alike

Older Age Predicts Biopsy and Radical Prostatectomy Grade Reclassification to Aggressive Prostate Cancer in Men on Active Surveillance

Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations

Outcomes of arterial resection during pancreatectomy for tumor

Outcomes of very high-risk prostate cancer after radical prostatectomy: Validation study from 3 centers

Overtreatment and underutilization of watchful waiting in men with limited life expectancy: an analysis of the Michigan Urological Surgery Improvement Collaborative Registry

PSA and beyond: the past, present, and future of investigative biomarkers for prostate cancer

PTEN Loss in Gleason Score 3 + 4 = 7 Prostate Biopsies is Associated with Nonorgan Confined Disease at Radical Prostatectomy

PTEN status assessment in the Johns Hopkins active surveillance cohort

Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery

Pathological Outcomes in Men with Low Risk and Very Low Risk Prostate Cancer: Implications on the Practice of Active Surveillance ⬇️

Patients with Intermediate Risk Prostate Cancer May be Good Candidates for Active Surveillance: Con

Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier

Pharmacodynamic and pharmacokinetic neoadjuvant study of hedgehog pathway inhibitor Sonidegib (LDE-225) in men with high-risk localized prostate cancer undergoing prostatectomy

Prediction of pathological stage based on clinical stage, serum prostate-specific antigen, and biopsy Gleason score: Partin Tables in the contemporary era.

Prevalence and Prognostic Significance of PTEN Loss in African-American and European-American Men Undergoing Radical Prostatectomy

Prognostic utility of biopsy-derived cell cycle progression score in patients with National Comprehensive Cancer Network low-risk prostate cancer undergoing radical prostatectomy: implications for treatment guidance

Prognostic value of prostate biopsy grade: forever a product of sampling

Prospective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsy

Prostate Health Index (PHI) Predicts High-stage Pathology in African American Men.

Prostate Health Index and Multiparametric MRI to Predict Prostate Cancer Grade Reclassification in Active Surveillance

Prostate Health Index density improves detection of clinically significant prostate cancer

Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis

Racial Variations in Prostate Cancer Molecular Subtypes and Androgen Receptor Signaling Reflect Anatomic Tumor Location

Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer

Radical retropubic prostatectomy: comparison of the open and robotic approaches for treatment of prostate cancer.

Readmissions after complex aneurysm repair are frequent, costly, and primarily at nonindex hospitals